Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
Fabio Di Domenico(Sapienza University of Rome), Marzia Perluigi(Sapienza University of Rome)
Cited by 67
Related Papers
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
|Translational Neurodegeneration|2018|100
Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal‐derived extracellular vesicles
|Alzheimer s & Dementia|2021|31
Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model
|Neurobiology of Disease|2024|14